On June 3, WuXi Biologics declined 3.36% in regular trading, trading at 33.66 HKD/share, with trading volume of 159 million HKD.
Within the Life Sciences Tools & Services sector where WuXi Biologics belongs, performance was broadly weak. Among individual stocks, GENSCRIPT BIO up 18.53%, WUXI APPTEC down 1.85%, XTALPI down 1.87%, WUXI XDC down 2.56%, INSILICO down 0.80%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)